Authors:
Norledge, BV
Lambeir, AM
Abagyan, RA
Rottmann, A
Fernandez, AM
Filimonov, VV
Peter, MG
Wierenga, RK
Citation: Bv. Norledge et al., Modeling, mutagenesis, and structural studies on the fully conserved phosphate-binding loop (loop 8) of triosephosphate isomerase: Toward a new substrate specificity, PROTEINS, 42(3), 2001, pp. 383-389
Authors:
Lambeir, AM
Proost, P
Durinx, C
Bal, G
Senten, K
Augustyns, K
Scharpe, S
Van Damme, J
De Meester, I
Citation: Am. Lambeir et al., Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidaseIV reveals a striking selectivity within the chemokine family, J BIOL CHEM, 276(32), 2001, pp. 29839-29845
Authors:
Lambeir, AM
Durinx, C
Proost, P
Van Damme, J
Scharpe, S
De Meester, I
Citation: Am. Lambeir et al., Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion, FEBS LETTER, 507(3), 2001, pp. 327-330
Authors:
Kursula, I
Partanen, S
Lambeir, AM
Antonov, DM
Augustyns, K
Wierenga, RK
Citation: I. Kursula et al., Structural determinants for ligand binding and catalysis of triosephosphate isomerase, EUR J BIOCH, 268(19), 2001, pp. 5189-5196
Authors:
Proost, P
Schutyser, E
Menten, P
Struyf, S
Wuyts, A
Opdenakker, G
Detheux, M
Parmentier, M
Durinx, C
Lambeir, AM
Neyts, J
Liekens, S
Maudgal, PC
Billiau, A
Van Damme, J
Citation: P. Proost et al., Amino-terminal truncation of CXCR3 agonists impairs receptor signaling andlymphocyte chemotaxis, while preserving antiangiogenic properties, BLOOD, 98(13), 2001, pp. 3554-3561
Authors:
Lambeir, AM
Backmann, J
Ruiz-Sanz, J
Filimonov, V
Nielsen, JE
Kursula, I
Norledge, BV
Wierenga, RK
Citation: Am. Lambeir et al., The ionization of a buried glutamic acid is thermodynamically linked to the stability of Leishmania mexicana triose phosphate isomerase, EUR J BIOCH, 267(9), 2000, pp. 2516-2524
Authors:
Durinx, C
Lambeir, AM
Bosmans, E
Falmagne, JB
Berghmans, R
Haemers, A
Scharpe, S
De Meester, I
Citation: C. Durinx et al., Molecular characterization of dipeptidyl peptidase activity in serum - Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides, EUR J BIOCH, 267(17), 2000, pp. 5608-5613
Authors:
Zhang, XY
De Meester, I
Lambeir, AM
Dillen, L
Van Dongen, W
Esmans, EL
Haemers, A
Scharpe, S
Claeys, M
Citation: Xy. Zhang et al., Study of the enzymatic degradation of vasostatin I and II and their precursor chromogranin A by dipeptidyl peptidase IV using high-performance liquidchromatography electrospray mass spectrometry, J MASS SPEC, 34(4), 1999, pp. 255-263
Authors:
Augustyns, K
Bal, G
Thonus, G
Belyaev, A
Zhang, XM
Bollaert, W
Lambeir, AM
Durinx, C
Goossens, F
Haemers, A
Citation: K. Augustyns et al., The unique properties of dipeptidyl-peptidase IV (DPP IV/CD26) and the therapeutic potential of DPP IV inhibitors, CURR MED CH, 6(4), 1999, pp. 311-327
Authors:
Williams, JC
Zeelen, JP
Neubauer, G
Vriend, G
Backmann, J
Michels, PAM
Lambeir, AM
Wierenga, RK
Citation: Jc. Williams et al., Structural and mutagenesis studies of leishmania triosephosphate isomerase: a point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power, PROTEIN ENG, 12(3), 1999, pp. 243-250
Authors:
Belyaev, A
Zhang, XM
Augustyns, K
Lambeir, AM
De Meester, I
Vedernikova, I
Scharpe, S
Haemers, A
Citation: A. Belyaev et al., Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors, J MED CHEM, 42(6), 1999, pp. 1041-1052
Authors:
Proost, P
Struyf, S
Schols, D
Opdenakker, G
Sozzani, S
Allavena, P
Mantovani, A
Augustyns, K
Bal, G
Haemers, A
Lambeir, AM
Scharpe, S
Van Damme, J
De Meester, I
Citation: P. Proost et al., Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IVbeyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction, J BIOL CHEM, 274(7), 1999, pp. 3988-3993